STXBP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.837400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.824000E-01
Normal-vs-Stage2
3.139400E-01
Normal-vs-Stage3
3.122000E-02
Normal-vs-Stage4
7.647800E-01
Stage1-vs-Stage2
8.623000E-01
Stage1-vs-Stage3
2.169400E-01
Stage1-vs-Stage4
7.274600E-01
Stage2-vs-Stage3
1.326560E-01
Stage2-vs-Stage4
4.724400E-01
Stage3-vs-Stage4
6.920500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.145000E-01
Normal-vs-AfricanAmerican
9.883600E-01
Normal-vs-Asian
5.675600E-01
Caucasian-vs-AfricanAmerican
3.800600E-01
Caucasian-vs-Asian
4.893400E-01
AfricanAmerican-vs-Asian
5.407000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.370400E-01
Normal-vs-Female
3.618800E-01
Male-vs-Female
3.350400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.648600E-01
Normal-vs-Age(41-60Yrs)
5.926600E-01
Normal-vs-Age(61-80Yrs)
1.912960E-01
Normal-vs-Age(81-100Yrs)
1.734240E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.016400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.927400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.243600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.262200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.899900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.392600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.608380E-01
Normal-vs-Daily Drinker
1.318390E-01
Normal-vs-Weekly Drinker
5.047700E-02
Normal-vs-Occasional Drinker
4.676000E-01
Normal-vs-Social Drinker
2.908800E-01
Non Drinker-vs-Daily Drinker
5.234200E-01
Non Drinker-vs-Weekly Drinker
2.167600E-01
Non Drinker-vs-Occasional Drinker
1.437820E-01
Non Drinker-vs-Social Drinker
5.316400E-01
Daily Drinker-vs-Weekly Drinker
5.643600E-01
Daily Drinker-vs-Occasional Drinker
6.527600E-02
Daily Drinker-vs-Social Drinker
2.798600E-01
Weekly Drinker-vs-Occasional Drinker
1.775540E-02
Weekly Drinker-vs-Social Drinker
1.026550E-01
Occasional Drinker-vs-Social Drinker
4.816800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.309200E-01
Normal-vs-Grade 2
8.779400E-03
Normal-vs-Grade 3
1.560250E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.751400E-01
Grade 1-vs-Grade 3
4.983600E-01
Grade 1-vs-Grade 4
1.309200E-01
Grade 2-vs-Grade 3
9.869200E-01
Grade 2-vs-Grade 4
8.779400E-03
Grade 3-vs-Grade 4
1.560250E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.271210E-01
Normal-vs-NonDiabetic
1.825970E-01
Diabetic-vs-NonDiabetic
3.961600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.137840E-01
Normal-vs-NoPancreatitis
1.899230E-01
Pancreatitis-vs-NoPancreatitis
3.861200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.807000E-01
Normal-vs-N1
3.112200E-01
N0-vs-N1
4.743000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.813200E-01
Normal-vs-TP53-NonMutant
3.962200E-01
TP53-Mutant-vs-TP53-NonMutant
2.701200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
